Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PB9453 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-Versican/VCAN Antibody Picoband™
- Antibody type
- Polyclonal
- Description
- Polyclonal antibody for Versican/VCAN detection. Host: Rabbit.Size: 100μg/vial. Tested applications: IHC-P. Reactive species: Human. Versican/VCAN information: Molecular Weight: 372820 MW; Subcellular Localization: Secreted, extracellular space, extracellular matrix; Tissue Specificity: Cerebral white matter and plasma. Isoform V0 and isoform V1 are expressed in normal brain, gliomas, medulloblastomas, schwannomas, neurofibromas, and meningiomas. Isoform V2 is restricted to normal brain and gliomas. Isoform V3 is found in all these tissues except medulloblastomas.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references The Role of CCL20-CCR6 Axis in Ovarian Cancer Metastasis.
Glycosylation of dentin matrix protein 1 is critical for fracture healing via promoting chondrogenesis.
miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy.
Liu W, Wang W, Zhang N, Di W
OncoTargets and therapy 2020;13:12739-12750
OncoTargets and therapy 2020;13:12739-12750
Glycosylation of dentin matrix protein 1 is critical for fracture healing via promoting chondrogenesis.
Xue H, Tao D, Weng Y, Fan Q, Zhou S, Zhang R, Zhang H, Yue R, Wang X, Wang Z, Sun Y
Frontiers of medicine 2019 Oct;13(5):575-589
Frontiers of medicine 2019 Oct;13(5):575-589
miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
Salem M, O'Brien JA, Bernaudo S, Shawer H, Ye G, Brkić J, Amleh A, Vanderhyden BC, Refky B, Yang BB, Krylov SN, Peng C
Cancer research 2018 Aug 1;78(15):4175-4190
Cancer research 2018 Aug 1;78(15):4175-4190
Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy.
Fujii K, Karpova MB, Asagoe K, Georgiev O, Dummer R, Urosevic-Maiwald M
Leukemia 2015 Oct;29(10):2024-32
Leukemia 2015 Oct;29(10):2024-32
No comments: Submit comment
Supportive validation
- Submitted by
- Boster Biological Technology (provider)
- Main image
- Experimental details
- Anti- Versican Picoband antibody, PB9453, Western blottingAll lanes: Anti Versican (PB9453) at 0.5ug/mlLane 1: Rat Brain Tissue Lysate at 50ugLane 2: HEPA Whole Cell Lysate at 40ugPredicted bind size: 373KDObserved bind size: 373KD
- Additional image